Breast Cancer

Osteoporosis drug could be repurposed for breast cancer prevention 

An Australian-led international trial to investigate whether a common osteoporosis drug can delay or prevent breast cancer in women with an inherited BRCA1 mutation is actively recruiting. Previously published laboratory research by the co-principal investigator of the Breast Cancer Trials  BRCA-P trial, Professor Geoff Lindeman, suggested RANKL blockade was a promising strategy in the prevention of ...

Already a member?

Login to keep reading.

© 2022 the limbic